We are live on ! Find out more
LIVN icon

LivaNova

189 hedge funds and large institutions have $2.94B invested in LivaNova in 2017 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 72 increasing their positions, 58 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,813% more call options, than puts

Call options by funds: $22.5M | Put options by funds: $1.18M

136% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 14

24% more repeat investments, than reductions

Existing positions increased: 72 | Existing positions reduced: 58

19% more capital invested

Capital invested by funds: $2.46B → $2.94B (+$478M)

9% more funds holding

Funds holding: 174189 (+15)

3.64% more ownership

Funds ownership: 83.43%87.07% (+3.6%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
189
Holders Change
+15
Holders Change %
+8.62%
% of All Funds
4.71%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
33
Increased
72
Reduced
58
Closed
14
Calls
$22.5M
Puts
$1.18M
Net Calls
+$21.3M
Net Calls Change
+$21M
Name Holding Trade Value Shares
Change
Change in
Stake
Creative Planning
201
Creative Planning
Kansas
-$122K -2,000 Closed
AIM
202
Acrospire Investment Management
Illinois
-$86K -1,410 Closed
ASN
203
Advisory Services Network
Georgia
-$21K -350 Closed

LIVN Hedge Fund Activity: Q3 2017 in Review

189 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in LivaNova (LIVN) for Q3 2017, worth a combined $2.94B — up 19% from $2.46B a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new LIVN positions and 14 closed out — a net gain of 19 holders — while 72 added to existing stakes and 58 trimmed.

The largest buyer was HealthCor Management, adding an estimated $33.7M. The largest seller was Columbia Wanger Asset Management, cutting an estimated $32.1M.

  • 189 institutional investors held LivaNova (LIVN) as of Q3 2017, up from 174 in Q2 2017.
  • Funds reported $2.94B of LivaNova stock for Q3 2017, up 19% quarter-over-quarter.
  • 33 funds opened new LivaNova positions in Q3 2017 and 14 closed out, a net change of +19 holders.
  • The largest LivaNova buyer in Q3 2017 was HealthCor Management, an estimated $33.7M added.
  • The largest LivaNova seller in Q3 2017 was Columbia Wanger Asset Management, an estimated $32.1M sold.

Based on aggregated 13F filings for Q3 2017.